(PhysOrg.com) -- In new research on prostate cancer to bone metastasis, Dr. Phillip Trackman of Boston University Henry M. Goldman School of Dental Medicine explains that the lysyl oxidase pro-peptide (LOX-PP) inhibits prostate cancer cell growth in vitro by inhibiting the activity of a key growth factor known as Fibroblast Growth Factor 2, or FGF-2.
Full article >>
Monday, July 13, 2009
Preventing Prostate Cancer to Bone Metastasis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment